2025年全球诊断即服务市场报告

近年来，诊断即服务（DaaS）市场规模呈指数级增长，从2024年的44.5亿美元增长到2025年的54亿美元，复合年增长率达21.2%。这一增长主要与数位医疗的兴起、对疾病早期检测需求的增加、云端基础方案的广泛应用、不断上涨的医疗成本促使人们寻求更高效的解决方案，以及对更快、更准确的诊断的需求不断增长等因素相关。

预计未来几年，诊断即服务 (DaaS) 市场规模将呈指数级增长，到 2029 年将达到 115 亿美元，复合年增长率 (CAGR) 为 20.8%。预测期内的增长与慢性病患病率上升、个性化医疗的扩展、远端和居家检测需求的增长、对经济高效诊断的日益重视以及对数位医疗解决方案的支持性监管措施密切相关。预测期内的关键趋势包括：人工智慧驱动的诊断、云端基础的采用、多组学整合体学、远端和居家检测、具有数位彙报功能的即时分析、区块链数据安全以及以患者为中心的个人化诊断即服务。

预计未来几年，慢性病盛行率的上升将推动诊断即服务（DaaS）市场的扩张。慢性病是指需要持续医疗照护的长期健康状况，其流行往往与缺乏运动的生活方式有关。久坐不动的生活方式，例如长时间坐着和缺乏体能锻炼，会增加心臟病和糖尿病等疾病的风险。诊断即服务透过支援云端基础的检测和分析，促进长期健康监测，在慢性病管理中发挥关键作用。这项服务透过提供及时的资讯、减少频繁就医的需求以及改善慢性病患者的就医途径，从而提升了患者的护理品质。例如，英国国家医疗服务体系（NHS）在2024年6月报告称，2023年有3,615,330人被诊断患有非糖尿病性高血糖症（一种以血糖值升高为特征的疾病），比2022年增长了18%。这一趋势凸显了对持续监测日益增长的需求，并正在推动诊断即服务市场的发展。

个人化医疗的日益普及也推动了诊断即服务市场的成长。个人化医疗根据个人的基因组成、生活方式和环境来制定个人化的治疗和预防方案。这种方法的兴起主要归功于基因组学的进步，基因组学能够准确地识别基因变异并制定个人化治疗方案。诊断即服务透过提供云端基础的诊断工具来增强个人化医疗，这些工具能够快速、准确地评估患者病情。这些服务简化了资料收集和分析流程，支援客製化的治疗策略，并改善临床决策。例如，个人化医疗联盟在2024年2月报告称，美国食品药物管理局）在2023年核准了26种新的个人化药物。个人化医疗的快速普及正在推动诊断即服务市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球诊断即服务：PESTEL 分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
• 终端用户产业分析
• 全球诊断即服务市场：成长率分析
• 全球诊断即服务市场表现：规模与成长，2019-2024 年
• 全球诊断即服务市场预测：规模与成长，2024-2029年，2034年
• 全球诊断即服务：潜在市场规模 (TAM)

第六章 市场细分

• 全球诊断即服务市场按组件、效能和预测划分，2019-2024年、2024-2029年、2034年
• 软体
• 服务
• 平台
• 全球诊断即服务市场依部署模式、效能及预测划分，2019-2024年、2024-2029年、2034年
• 云端基础的
• 本地部署
• 杂交种
• 全球诊断即服务市场按应用、效能和预测划分，2019-2024年、2024-2029年、2034年
• 临床诊断
• 影像诊断
• 病理
• 基因组学
• 其他用途
• 全球诊断即服务市场（按最终用户、效能和预测划分），2019-2024 年、2024-2029 年、2034 年
• 医院和诊所
• 诊断实验室
• 研究所
• 其他最终用户
• 全球诊断即服务市场：依软体、类型、效能及预测细分，2019-2024年、2024-2029年、2034年
• 诊断分析软体
• 临床决策支援软体
• 基于人工智慧 (AI) 或机器学习 (ML) 的诊断工具
• 成像和视觉化软体
• 数据整合和互通性软体
• 远端监控和报告软体
• 全球诊断即服务市场：按服务、类型、效能和预测细分，2019-2024年、2024-2029年、2034年
• 诊断测试服务
• 远端/虚拟诊断服务
• 云端基础的资料储存和管理
• 咨询及实施服务
• 培训和支援服务
• 维护和升级服务
• 全球诊断即服务市场：按平台、类型、效能和预测细分，2019-2024年、2024-2029年、2034年
• 云端基础的诊断平台
• 本地诊断平台
• 混合部署平台
• 应用程式介面（API）和整合平台
• 移动或远距离诊断平台
• 资料交换与协作平台

第七章 区域和国家分析

• 全球诊断即服务市场：依地区、绩效及预测划分，2019-2024年、2024-2029年、2034年
• 全球诊断即服务市场：国家/地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

• 诊断即服务市场：竞争格局
• 诊断即服务市场：公司概况
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

• GE Healthcare Technologies Inc.
• Becton Dickinson and Company
• Agilent Technologies Inc.
• Hologic Inc.
• Bio-Rad Laboratories Inc.
• Guardant Health Inc.
• Invitae Corporation
• InHealth Group Limited
• Canon Medical Systems Corporation
• Freenome Holdings Inc.
• BioSerenity SAS
• PathAI Inc.
• Butterfly Network Inc.
• Aidoc Medical Ltd.
• Owkin Inc.

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

• 2029年诊断即服务市场：提供新机会的国家
• 2029年诊断即服务市场：提供新机会的细分市场
• 2029年诊断即服务市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手策略

第36章附录

Diagnostics-as-a-service is a cloud-based healthcare approach that offers diagnostic testing, analysis, and reporting via digital platforms, often utilizing artificial intelligence (AI), internet of things (IoT), and remote connectivity. It provides scalable, cost-efficient, and accessible diagnostic solutions without requiring extensive on-site infrastructure. The model supports real-time health monitoring, quicker decision-making, and better patient outcomes by optimizing diagnostic delivery across healthcare environments.

The primary elements of diagnostics-as-a-service are software, services, and hardware. Software includes cloud-based platforms that deliver on-demand diagnostic testing, analysis, and reporting, facilitating scalable, cost-effective, and accessible healthcare diagnostics. It can be implemented through cloud-based, on-premises, or hybrid systems. Applications cover clinical diagnostics, imaging, pathology, genomics, and more, serving hospitals, clinics, diagnostic laboratories, research institutes, and other users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The diagnostics-as-a-service market research report is one of a series of new reports from The Business Research Company that provides diagnostics-as-a-service market statistics, including the diagnostics-as-a-service industry global market size, regional shares, competitors with the diagnostics-as-a-service market share, detailed diagnostics-as-a-service market segments, market trends, and opportunities, and any further data you may need to thrive in the diagnostics-as-a-service industry. This diagnostics-as-a-service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The diagnostics-as-a-service market size has grown exponentially in recent years. It will grow from $4.45 billion in 2024 to $5.40 billion in 2025 at a compound annual growth rate (CAGR) of 21.2%. The growth in the historic period can be linked to the rise of digital healthcare, increasing demand for early disease detection, wider adoption of cloud-based solutions, growing healthcare costs driving the need for efficient approaches, and a heightened demand for faster, more accurate diagnostics.

The diagnostics-as-a-service market size is expected to see exponential growth in the next few years. It will grow to $11.50 billion in 2029 at a compound annual growth rate (CAGR) of 20.8%. The growth in the forecast period can be linked to the rising prevalence of chronic diseases, expansion of personalized medicine, growing demand for remote and home-based testing, increased focus on cost-effective diagnostics, and supportive regulatory measures for digital healthcare solutions. Key trends during the forecast period include the use of AI-driven diagnostics, adoption of cloud-based platforms, integrated multi-omics approaches, remote and at-home testing, real-time analytics with digital reporting, blockchain-enabled data security, and patient-centric, personalized diagnostic services.

The rising prevalence of chronic diseases is expected to drive the expansion of the diagnostics-as-a-service market in the coming years. Chronic diseases are long-lasting health conditions that require ongoing medical care, often becoming more prevalent due to inactive lifestyles. Sedentary behavior, such as prolonged sitting and minimal physical activity, increases the likelihood of developing conditions such as heart disease and diabetes. Diagnostics-as-a-service plays a crucial role in managing chronic diseases by enabling cloud-based testing and analysis, which facilitates the monitoring of long-term health conditions. This service enhances patient care by providing timely insights, reducing the need for frequent hospital visits, and improving accessibility for individuals with chronic health concerns. For example, in June 2024, the National Health Service in the UK reported that 3,615,330 individuals were diagnosed with non-diabetic hyperglycemia, a condition indicating elevated blood sugar levels, in 2023, an 18% increase from 2022. This trend highlights the growing demand for continuous monitoring, driving the diagnostics-as-a-service market.

The increasing adoption of personalized medicine is also contributing to the growth of the diagnostics-as-a-service market. Personalized medicine tailors treatment and prevention plans based on an individual's genetic makeup, lifestyle, and environment. The rise of this approach is largely due to advancements in genomics, which allow for the precise identification of genetic variations and the creation of individualized treatments. Diagnostics-as-a-service enhances personalized medicine by offering cloud-based diagnostic tools that provide rapid, accurate patient assessments. These services streamline data collection and analysis, supporting customized treatment strategies and improving clinical decision-making. For instance, in February 2024, the Personalized Medicine Coalition reported that the U.S. Food and Drug Administration approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. This surge in personalized medicine adoption is fueling the growth of the diagnostics-as-a-service market.

Companies in the diagnostics-as-a-service market are increasingly focusing on developing patient-centric solutions, such as at-home lab testing services, to improve convenience and accessibility. At-home lab testing services allow individuals to collect samples at home and receive test results without needing to visit a clinic. For example, in June 2025, Amazon India partnered with Orange Health Labs to launch Amazon Diagnostics, an at-home lab testing service under Amazon Medical. Available in six major cities, the service offers doorstep sample collection within 60 minutes and delivers digital reports in as little as six hours, covering over 800 diagnostic tests. Customers can book, track, and access secure test results through the Amazon app. This initiative addresses key challenges in India's diagnostic sector, such as delays, accessibility, and quality, while aligning with Amazon's broader goal of providing comprehensive healthcare services, including pharmacy and clinics.

Major players in the diagnostics-as-a-service market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Becton Dickinson and Company, Agilent Technologies Inc., Hologic Inc., Bio-Rad Laboratories Inc., Guardant Health Inc., Invitae Corporation, InHealth Group Limited, Canon Medical Systems Corporation, Freenome Holdings Inc., BioSerenity SAS, PathAI Inc., Butterfly Network Inc., Aidoc Medical Ltd., Owkin Inc., K Health Inc., and Probatix GmbH.

North America was the largest region in the diagnostics-as-a-service market in 2024. The regions covered in diagnostics-as-a-service report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the diagnostics-as-a-service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diagnostics-as-a-service market includes revenues earned by entities through remote diagnostic testing, laboratory analysis, sample collection and processing, cloud-based reporting, and teleconsultation for test interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diagnostics-As-A-Service Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diagnostics-as-a-service market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diagnostics-as-a-service ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diagnostics-as-a-service market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Software; Services; Platforms
• 2) By Deployment Mode: Cloud-Based; On-Premises; Hybrid
• 3) By Application: Clinical Diagnostics; Imaging Diagnostics; Pathology; Genomics; Other Applications
• 4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Other End Users
• Subsegments:
• 1) By Software: Diagnostic Analytics Software; Clinical Decision Support Software; Artificial Intelligence (AI) Or Machine Learning (ML)-Based Diagnostic Tools; Imaging And Visualization Software; Data Integration And Interoperability Software; Remote Monitoring And Reporting Software
• 2) By Services: Diagnostic Testing Services; Remote And Virtual Diagnostic Services; Cloud-Based Data Storage And Management; Consulting And Implementation Services; Training And Support Services; Maintenance And Upgradation Services
• 3) By Platforms: Cloud-based Diagnostic Platforms; On-Premise Diagnostic Platforms; Hybrid Deployment Platforms; Application Programming Interface (API) And Integration Platforms; Mobile Or Tele-Diagnostics Platforms; Data Exchange And Collaboration Platforms
• Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers AG; Koninklijke Philips N.V.; GE Healthcare Technologies Inc.; Becton Dickinson and Company; Agilent Technologies Inc.; Hologic Inc.; Bio-Rad Laboratories Inc.; Guardant Health Inc.; Invitae Corporation; InHealth Group Limited; Canon Medical Systems Corporation; Freenome Holdings Inc.; BioSerenity SAS; PathAI Inc.; Butterfly Network Inc.; Aidoc Medical Ltd.; Owkin Inc.; K Health Inc.; Probatix GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Diagnostics-As-A-Service Market Characteristics

3. Diagnostics-As-A-Service Market Trends And Strategies

4. Diagnostics-As-A-Service Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Diagnostics-As-A-Service Growth Analysis And Strategic Analysis Framework

• 5.1. Global Diagnostics-As-A-Service PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Diagnostics-As-A-Service Market Growth Rate Analysis
• 5.4. Global Diagnostics-As-A-Service Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Diagnostics-As-A-Service Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Diagnostics-As-A-Service Total Addressable Market (TAM)

6. Diagnostics-As-A-Service Market Segmentation

• 6.1. Global Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software
• Services
• Platforms
• 6.2. Global Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cloud-Based
• On-Premises
• Hybrid
• 6.3. Global Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinical Diagnostics
• Imaging Diagnostics
• Pathology
• Genomics
• Other Applications
• 6.4. Global Diagnostics-As-A-Service Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Diagnostic Laboratories
• Research Institutes
• Other End Users
• 6.5. Global Diagnostics-As-A-Service Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Analytics Software
• Clinical Decision Support Software
• Artificial Intelligence (AI) Or Machine Learning (ML)-Based Diagnostic Tools
• Imaging And Visualization Software
• Data Integration And Interoperability Software
• Remote Monitoring And Reporting Software
• 6.6. Global Diagnostics-As-A-Service Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Testing Services
• Remote And Virtual Diagnostic Services
• Cloud-Based Data Storage And Management
• Consulting And Implementation Services
• Training And Support Services
• Maintenance And Upgradation Services
• 6.7. Global Diagnostics-As-A-Service Market, Sub-Segmentation Of Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cloud-Based Diagnostic Platforms
• On-premise Diagnostic Platforms
• Hybrid Deployment Platforms
• Application Programming Interface (API) And Integration Platforms
• Mobile Or Tele-diagnostics Platforms
• Data Exchange And Collaboration Platforms

7. Diagnostics-As-A-Service Market Regional And Country Analysis

• 7.1. Global Diagnostics-As-A-Service Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Diagnostics-As-A-Service Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Diagnostics-As-A-Service Market

• 8.1. Asia-Pacific Diagnostics-As-A-Service Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Diagnostics-As-A-Service Market

• 9.1. China Diagnostics-As-A-Service Market Overview
• 9.2. China Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Diagnostics-As-A-Service Market

• 10.1. India Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Diagnostics-As-A-Service Market

• 11.1. Japan Diagnostics-As-A-Service Market Overview
• 11.2. Japan Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Diagnostics-As-A-Service Market

• 12.1. Australia Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Diagnostics-As-A-Service Market

• 13.1. Indonesia Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Diagnostics-As-A-Service Market

• 14.1. South Korea Diagnostics-As-A-Service Market Overview
• 14.2. South Korea Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Diagnostics-As-A-Service Market

• 15.1. Western Europe Diagnostics-As-A-Service Market Overview
• 15.2. Western Europe Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Diagnostics-As-A-Service Market

• 16.1. UK Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Diagnostics-As-A-Service Market

• 17.1. Germany Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Diagnostics-As-A-Service Market

• 18.1. France Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Diagnostics-As-A-Service Market

• 19.1. Italy Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Diagnostics-As-A-Service Market

• 20.1. Spain Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Diagnostics-As-A-Service Market

• 21.1. Eastern Europe Diagnostics-As-A-Service Market Overview
• 21.2. Eastern Europe Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Diagnostics-As-A-Service Market

• 22.1. Russia Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Diagnostics-As-A-Service Market

• 23.1. North America Diagnostics-As-A-Service Market Overview
• 23.2. North America Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Diagnostics-As-A-Service Market

• 24.1. USA Diagnostics-As-A-Service Market Overview
• 24.2. USA Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Diagnostics-As-A-Service Market

• 25.1. Canada Diagnostics-As-A-Service Market Overview
• 25.2. Canada Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Diagnostics-As-A-Service Market

• 26.1. South America Diagnostics-As-A-Service Market Overview
• 26.2. South America Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Diagnostics-As-A-Service Market

• 27.1. Brazil Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Diagnostics-As-A-Service Market

• 28.1. Middle East Diagnostics-As-A-Service Market Overview
• 28.2. Middle East Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Diagnostics-As-A-Service Market

• 29.1. Africa Diagnostics-As-A-Service Market Overview
• 29.2. Africa Diagnostics-As-A-Service Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Diagnostics-As-A-Service Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Diagnostics-As-A-Service Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Diagnostics-As-A-Service Market Competitive Landscape And Company Profiles

• 30.1. Diagnostics-As-A-Service Market Competitive Landscape
• 30.2. Diagnostics-As-A-Service Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

31. Diagnostics-As-A-Service Market Other Major And Innovative Companies

• 31.1. GE Healthcare Technologies Inc.
• 31.2. Becton Dickinson and Company
• 31.3. Agilent Technologies Inc.
• 31.4. Hologic Inc.
• 31.5. Bio-Rad Laboratories Inc.
• 31.6. Guardant Health Inc.
• 31.7. Invitae Corporation
• 31.8. InHealth Group Limited
• 31.9. Canon Medical Systems Corporation
• 31.10. Freenome Holdings Inc.
• 31.11. BioSerenity SAS
• 31.12. PathAI Inc.
• 31.13. Butterfly Network Inc.
• 31.14. Aidoc Medical Ltd.
• 31.15. Owkin Inc.

32. Global Diagnostics-As-A-Service Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diagnostics-As-A-Service Market

34. Recent Developments In The Diagnostics-As-A-Service Market

35. Diagnostics-As-A-Service Market High Potential Countries, Segments and Strategies

• 35.1 Diagnostics-As-A-Service Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Diagnostics-As-A-Service Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Diagnostics-As-A-Service Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer